10-Q · 2026-11-05
LB Pharmaceuticals Inc. releases its Q3 2026 results, emphasizing ongoing investments in R&D crucial for its growth in the pharmaceutical industry.
| Name | LB PHARMACEUTICALS INC |
|---|---|
| CIK | 0001691082 |
| Tickers | LBRX |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 000000000 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 917-450-6581 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
LB Pharmaceuticals Inc. releases its Q3 2026 results, emphasizing ongoing investments in R&D crucial for its growth in the pharmaceutical industry.
146 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-464051 | 005-95235 | 261563412 | 34 | 14597 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001831942-26-000053 | 005-95235 | 261562745 | 34 | 15588 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001493152-26-052394 | 005-95235 | 261561122 | 34 | 11869 | |||
| 2026-11-05 | 10-Q | 10-Q | 0001193125-26-449994 | 001-42831 | 261527950 | 34 | 15543185 | 1 | 1 | |
| 2026-11-05 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-449887 | 001-42831 | 261527586 | 34 | 215901 | 1 | 1 |
| 2026-10-13 | 4 | xslF345X06/form4-10132026_041004.xml | 0001746372-26-000007 | 5908 | ||||||
| 2026-10-13 | 4 | xslF345X06/form4-10132026_041001.xml | 0002150267-26-000005 | 5852 | ||||||
| 2026-10-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000019617-26-000360 | 005-95235 | 261456291 | 34 | 6940 | |||
| 2026-10-05 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-003150 | 333-294900 | 261442234 | 33 | 1817 | ||
| 2026-10-01 | POS AM | POS AM | 0001193125-26-410664 | 333-294900 | 261431416 | 33 | 20131 | |||
| 2026-10-01 | S-3ASR | S-3ASR | 0001193125-26-410651 | 333-299235 | 261431359 | 33 | 2249817 | 1 | 1 | |
| 2026-09-24 | 3 | xslF345X06/form3-09242026_080952.xml | 0002150267-26-000003 | 10047 | ||||||
| 2026-09-15 | 424B3 | 424B3 | 0001193125-26-391384 | 333-294900 | 261379190 | 33 | 39665 | |||
| 2026-09-15 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-26-391358 | 001-42831 | 261379166 | 34 | 174695 | 1 | 1 |
| 2026-09-14 | 3 | xslF345X06/form3-09142026_080925.xml | 0001746372-26-000005 | 10110 | ||||||
| 2026-09-03 | 424B3 | 424B3 | 0001193125-26-381100 | 333-294900 | 261356763 | 33 | 38680 | |||
| 2026-09-03 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-26-381076 | 001-42831 | 261356748 | 34 | 174495 | 1 | 1 |
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-352336 | 005-95235 | 261282087 | 34 | 14451 | |||
| 2026-08-11 | 424B3 | 424B3 | 0001193125-26-343542 | 333-294900 | 261260795 | 33 | 3304581 | |||
| 2026-08-11 | 10-Q | 10-Q | 0001193125-26-343490 | 001-42831 | 261260703 | 34 | 12924069 | 1 | 1 | |
| 2026-08-11 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-343479 | 001-42831 | 261260694 | 34 | 211342 | 1 | 1 |
| 2026-08-03 | 4 | 4 | 0001193125-26-331058 | 12977 | ||||||
| 2026-07-29 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-002809 | 005-95235 | 261216899 | 34 | 10901 | |||
| 2026-07-29 | 424B3 | 424B3 | 0001193125-26-322276 | 333-294900 | 261214096 | 33 | 44718 | |||
| 2026-07-29 | 8-K | 8-K | 1.01,3.02,7.01,9.01 | 0001193125-26-322208 | 001-42831 | 261214037 | 34 | 623191 | 1 | 1 |
| 2026-07-22 | 424B3 | 424B3 | 0001193125-26-311394 | 333-294900 | 261191795 | 33 | 29359 | |||
| 2026-07-22 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-311357 | 001-42831 | 261191702 | 34 | 162860 | 1 | 1 |
| 2026-07-16 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000019617-26-000264 | 005-95235 | 261180350 | 34 | 7160 | |||
| 2026-06-10 | 424B3 | 424B3 | 0001193125-26-266020 | 333-294900 | 261080500 | 33 | 36583 | |||
| 2026-06-10 | 8-K | 8-K | 5.02,9.01 | 0001193125-26-265867 | 001-42831 | 261079877 | 34 | 219880 | 1 | 1 |
| 2026-06-09 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000189 | 001-42831 | 261077299 | 33 | 4285 | |||
| 2026-06-09 | 424B3 | 424B3 | 0001193125-26-263737 | 333-294900 | 261076150 | 33 | 65572 | |||
| 2026-06-09 | 8-K | 8-K | 5.07 | 0001193125-26-263724 | 001-42831 | 261076079 | 34 | 147011 | 1 | 1 |
| 2026-06-05 | 4 | xslF345X06/form4-06052026_100631.xml | 0001187308-26-000002 | 5671 | ||||||
| 2026-06-05 | 4 | xslF345X06/form4-06052026_090603.xml | 0001609805-26-000003 | 5686 | ||||||
| 2026-06-05 | 4 | xslF345X06/form4-06052026_090613.xml | 0002031342-26-000002 | 5685 | ||||||
| 2026-06-05 | 4 | xslF345X06/form4-06052026_090641.xml | 0001992908-26-000011 | 5954 | ||||||
| 2026-06-05 | 4 | xslF345X06/form4-06052026_090613.xml | 0001771213-26-000002 | 5651 | ||||||
| 2026-06-05 | 4 | xslF345X06/form4-06052026_090647.xml | 0001813937-26-000003 | 5702 | ||||||
| 2026-06-05 | 4 | xslF345X06/form4-06052026_090631.xml | 0001533228-26-000006 | 5665 | ||||||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-226892 | 005-95235 | 26988272 | 34 | 13522 | |||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001831942-26-000020 | 005-95235 | 26987483 | 34 | 15589 | |||
| 2026-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001727492-26-000009 | 005-95235 | 26983816 | 34 | 9963 | |||
| 2026-05-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000019617-26-000216 | 005-95235 | 26971682 | 34 | 7154 | |||
| 2026-05-12 | 424B3 | 424B3 | 0001193125-26-219851 | 333-294900 | 26969848 | 33 | 2677725 | |||
| 2026-05-12 | 10-Q | 10-Q | 0001193125-26-219607 | 001-42831 | 26969156 | 34 | 10821595 | 1 | 1 | |
| 2026-05-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-219529 | 001-42831 | 26968934 | 34 | 199733 | 1 | 1 |
| 2026-04-23 | ARS | ARS | 0001193125-26-173732 | 001-42831 | 26888809 | 34 | 5551736 | |||
| 2026-04-23 | DEFA14A | DEFA14A | 0001193125-26-173708 | 001-42831 | 26888746 | 34 | 1007224 | |||
| 2026-04-23 | DEF 14A | DEF 14A | 0001193125-26-173679 | 001-42831 | 26888652 | 34 | 1503076 | 1 | 1 | |
| 2026-04-14 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-001186 | 333-294900 | 26862415 | 33 | 1803 | ||
| 2026-04-14 | 424B3 | 424B3 | 0001193125-26-155011 | 333-294900 | 26861362 | 33 | 686625 | |||
| 2026-04-10 | CORRESP | filename1.htm | 0001193125-26-151255 | 6868 | ||||||
| 2026-04-10 | UPLOAD | filename1.pdf | 0000000000-26-003643 | 333-294900 | 40107 | |||||
| 2026-04-06 | S-1 | S-1 | 0001193125-26-143724 | 333-294900 | 26841198 | 33 | 950504 | 1 | 1 | |
| 2026-03-26 | S-8 | S-8 | 0001193125-26-126539 | 333-294656 | 26799164 | 33 | 236825 | 1 | 1 | |
| 2026-03-26 | 10-K | 10-K | 0001193125-26-126368 | 001-42831 | 26798755 | 34 | 21258603 | 1 | 1 | |
| 2026-03-26 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-126223 | 001-42831 | 26798185 | 34 | 211143 | 1 | 1 |
| 2026-03-16 | 8-K | 8-K | 5.02 | 0001193125-26-108474 | 001-42831 | 26757455 | 34 | 143700 | 1 | 1 |
| 2026-03-10 | 4 | xslF345X05/form4-03102026_080331.xml | 0001992908-26-000007 | 5550 | ||||||
| 2026-03-10 | 3 | xslF345X02/form3-03102026_080333.xml | 0001992908-26-000005 | 9893 | ||||||
| 2026-03-10 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-26-099419 | 001-42831 | 26737295 | 34 | 164544 | 1 | 1 |
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001346824-26-000049 | 005-95235 | 26642425 | 34 | 14543 | |||
| 2026-02-10 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001193125-26-044781 | 005-95235 | 26616505 | 34 | 16969 | |||
| 2026-02-10 | 4 | 4 | 0001193125-26-044776 | 15069 | ||||||
| 2026-02-05 | 8-K | 8-K | 1.01,3.02,7.01,8.01,9.01 | 0001193125-26-038539 | 001-42831 | 26600633 | 34 | 613686 | 1 | 1 |
| 2026-01-21 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0002012383-26-000685 | 005-95235 | 26545912 | 34 | 10727 | |||
| 2026-01-21 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-26-000189 | 005-95235 | 26545737 | 34 | 10736 | |||
| 2026-01-21 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000019617-26-000044 | 005-95235 | 26544852 | 34 | 6726 | |||
| 2025-12-31 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001493152-25-029833 | 005-95235 | 251617884 | 34 | 24379 | |||
| 2025-12-11 | 4 | xslF345X05/form4-12112025_041206.xml | 0002095250-25-000006 | 5779 | ||||||
| 2025-11-18 | 3 | xslF345X02/form3-11182025_111154.xml | 0002095250-25-000002 | 9397 | ||||||
| 2025-11-13 | 8-K | 8-K | 1.01,9.01 | 0001193125-25-279074 | 001-42831 | 251475551 | 34 | 227289 | 1 | 1 |
| 2025-11-12 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-276070 | 001-42831 | 251469193 | 34 | 159458 | 1 | 1 |
| 2025-11-06 | 10-Q | 10-Q | 0001193125-25-268174 | 001-42831 | 251456317 | 34 | 11412120 | 1 | 1 | |
| 2025-11-06 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-268154 | 001-42831 | 251456290 | 34 | 229297 | 1 | 1 |
| 2025-10-17 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-25-003591 | 005-95235 | 251399658 | 34 | 10686 | |||
| 2025-09-29 | 4 | xslF345X05/form4-09302025_120930.xml | 0001304340-25-000006 | 28139 | ||||||
| 2025-09-29 | 3 | xslF345X02/form3-09302025_120959.xml | 0001304340-25-000004 | 15295 | ||||||
| 2025-09-25 | SCHEDULE 13D | xslSCHEDULE_13D_X01/primary_doc.xml | 0001213900-25-091474 | 005-95235 | 251340908 | 34 | 26497 | |||
| 2025-09-19 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001346824-25-000005 | 005-95235 | 251327414 | 34 | 18792 | |||
| 2025-09-19 | SCHEDULE 13D | xslSCHEDULE_13D_X01/primary_doc.xml | 0001193125-25-209153 | 005-95235 | 251327199 | 34 | 423124 | |||
| 2025-09-18 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001193125-25-207440 | 005-95235 | 251323747 | 34 | 115272 | |||
| 2025-09-18 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001831942-25-000020 | 005-95235 | 251323418 | 34 | 15008 | |||
| 2025-09-16 | 4 | xslF345X05/form4-09162025_100907.xml | 0002015536-25-000007 | 15060 | ||||||
| 2025-09-16 | 3 | xslF345X02/form3-09162025_100901.xml | 0002077950-25-000004 | 5161 | ||||||
| 2025-09-16 | 4 | xslF345X05/form4-09162025_040904.xml | 0001726334-25-000003 | 11458 | ||||||
| 2025-09-16 | 4 | xslF345X05/form4-09162025_040901.xml | 0001609805-25-000006 | 11205 | ||||||
| 2025-09-16 | 4 | 4 | 0001193125-25-204935 | 24581 | ||||||
| 2025-09-12 | 4 | xslF345X05/form4-09122025_060919.xml | 0001415889-25-024452 | 5493 | ||||||
| 2025-09-12 | 4 | xslF345X05/form4-09122025_060917.xml | 0001415889-25-024451 | 5527 | ||||||
| 2025-09-12 | 4 | xslF345X05/form4-09122025_060915.xml | 0001415889-25-024450 | 5544 | ||||||
| 2025-09-12 | 4 | xslF345X05/form4-09122025_060913.xml | 0001415889-25-024449 | 19140 | ||||||
| 2025-09-12 | 4 | xslF345X05/form4-09122025_060911.xml | 0001415889-25-024448 | 27929 | ||||||
| 2025-09-12 | 4 | xslF345X05/form4-09122025_100911.xml | 0001415889-25-024447 | 5528 | ||||||
| 2025-09-12 | 4 | xslF345X05/form4-09122025_060909.xml | 0001415889-25-024446 | 15217 | ||||||
| 2025-09-12 | 4 | xslF345X05/form4-09122025_060907.xml | 0001415889-25-024445 | 10767 | ||||||
| 2025-09-12 | 4 | xslF345X05/form4-09122025_060905.xml | 0001415889-25-024444 | 15331 | ||||||
| 2025-09-12 | 4 | xslF345X05/form4-09122025_060903.xml | 0001415889-25-024443 | 10842 | ||||||
| 2025-09-12 | 4 | xslF345X05/form4-09122025_060901.xml | 0001415889-25-024442 | 14995 | ||||||
| 2025-09-12 | 8-K | 8-K | 5.03,9.01 | 0001193125-25-202195 | 001-42831 | 251311540 | 34 | 185542 | 1 | 1 |
| 2025-09-12 | 424B4 | 424B4 | 0001193125-25-201757 | 333-289812 | 251310021 | 33 | 6788857 | |||
| 2025-09-11 | 3 | xslF345X02/form3-09112025_100919.xml | 0001415889-25-024307 | 9799 | ||||||
| 2025-09-11 | 3 | xslF345X02/form3-09112025_030927.xml | 0001415889-25-024255 | 5965 | ||||||
| 2025-09-11 | 3 | xslF345X02/form3-09112025_010950.xml | 0001415889-25-024247 | 10902 | ||||||
| 2025-09-11 | S-8 | S-8 | 0001193125-25-200401 | 333-290180 | 251306956 | 33 | 266144 | 1 | 1 | |
| 2025-09-10 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-002913 | 333-289812 | 251307153 | 33 | 1804 | ||
| 2025-09-10 | 3 | xslF345X02/form3-09112025_120941.xml | 0001415889-25-024200 | 22295 | ||||||
| 2025-09-10 | S-1MEF | S-1MEF | 0001193125-25-200422 | 333-290182 | 251306998 | 33 | 187397 | 1 | 1 | |
| 2025-09-10 | 3 | xslF345X02/form3-09102025_110950.xml | 0001415889-25-024192 | 9849 | ||||||
| 2025-09-10 | 3 | xslF345X02/form3-09102025_110936.xml | 0001415889-25-024190 | 9012 | ||||||
| 2025-09-10 | 3 | xslF345X02/form3-09102025_110937.xml | 0001415889-25-024188 | 8303 | ||||||
| 2025-09-10 | 3 | xslF345X02/form3-09102025_110926.xml | 0001415889-25-024186 | 11191 | ||||||
| 2025-09-10 | 3 | xslF345X02/form3-09102025_110914.xml | 0001415889-25-024184 | 8276 | ||||||
| 2025-09-10 | 3 | xslF345X02/form3-09102025_110945.xml | 0001415889-25-024181 | 8321 | ||||||
| 2025-09-10 | 3 | xslF345X02/form3-09102025_110950.xml | 0001415889-25-024179 | 11168 | ||||||
| 2025-09-10 | 3 | xslF345X02/form3-09102025_110949.xml | 0001415889-25-024177 | 16283 | ||||||
| 2025-09-10 | 3 | xslF345X02/form3-09102025_110936.xml | 0001415889-25-024175 | 12925 | ||||||
| 2025-09-10 | 3 | xslF345X02/form3-09102025_110935.xml | 0001415889-25-024173 | 11903 | ||||||
| 2025-09-10 | CERT | LBRX_8A_Cert_1691082.pdf | 0001354457-25-000881 | 001-42831 | 251305167 | 34 | 123936 | |||
| 2025-09-09 | CORRESP | filename1.htm | 0001193125-25-198853 | 10802 | ||||||
| 2025-09-09 | CORRESP | filename1.htm | 0001193125-25-198852 | 7376 | ||||||
| 2025-09-09 | 8-A12B | 8-A12B | 0001193125-25-198793 | 001-42831 | 251301662 | 34 | 14319 | |||
| 2025-09-08 | S-1/A | S-1/A | 0001193125-25-197877 | 333-289812 | 251298829 | 33 | 8466890 | 1 | 1 | |
| 2025-09-03 | CORRESP | filename1.htm | 0001193125-25-195145 | 62495 | ||||||
| 2025-08-22 | CORRESP | filename1.htm | 0001193125-25-186474 | 17881 | ||||||
| 2025-08-22 | S-1 | S-1 | 0001193125-25-186467 | 333-289812 | 251246931 | 33 | 11319621 | 1 | 1 | |
| 2025-08-12 | UPLOAD | filename1.pdf | 0000000000-25-008434 | 377-07237 | 43842 | |||||
| 2025-07-23 | DRSLTR | filename1.htm | 0000950123-25-006558 | 15520 | ||||||
| 2025-07-23 | DRS/A | filename1.htm | 0000950123-25-006557 | 377-07237 | 251143906 | 33 | 6417328 | |||
| 2024-07-02 | UPLOAD | filename1.pdf | 0000000000-24-007549 | 377-07237 | 42983 | |||||
| 2024-06-24 | DRSLTR | filename1.htm | 0000950123-24-006301 | 64191 | ||||||
| 2024-06-24 | DRS/A | filename1.htm | 0000950123-24-006300 | 377-07237 | 241064147 | 33 | 4899992 | |||
| 2024-06-17 | UPLOAD | filename1.pdf | 0000000000-24-006957 | 377-07237 | 67509 | |||||
| 2024-05-20 | DRS | filename1.htm | 0000950123-24-005777 | 377-07237 | 24966002 | 33 | 7872728 | |||
| 2024-01-10 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001691082-24-000001 | 021-492682 | 24526340 | 33 | 13984 | ||
| 2023-09-21 | D | xslFormDX01/primary_doc.xml | 06b | 0001691082-23-000004 | 021-492682 | 231268503 | 33 | 13869 | ||
| 2022-11-23 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001567619-22-020814 | 021-463476 | 221415219 | 33 | 10107 | ||
| 2022-11-01 | D | xslFormDX01/primary_doc.xml | 06b | 0001567619-22-018986 | 021-463476 | 221349496 | 33 | 10009 | ||
| 2022-07-06 | D | xslFormDX01/primary_doc.xml | 06b | 0001567619-22-013710 | 021-451258 | 221067935 | 33 | 10048 | ||
| 2020-09-01 | D | xslFormDX01/primary_doc.xml | 06b | 0001567619-20-016229 | 021-374620 | 201154399 | 33 | 10000 | ||
| 2018-12-12 | D | xslFormDX01/primary_doc.xml | 06b | 0001691082-18-000003 | 021-327722 | 181230581 | 33 | 12124 | ||
| 2018-08-27 | D | xslFormDX01/primary_doc.xml | 06b | 0001691082-18-000002 | 021-320086 | 181038605 | 33 | 9085 | ||
| 2018-05-29 | D | xslFormDX01/primary_doc.xml | 06b | 0001691082-18-000001 | 021-313419 | 18864240 | 33 | 9200 | ||
| 2017-04-06 | D | xslFormDX01/primary_doc.xml | 06b | 0001691082-17-000001 | 021-284184 | 17744737 | 33 | 9084 | ||
| 2016-12-15 | D | xslFormDX01/primary_doc.xml | 06b | 0001691082-16-000001 | 021-276363 | 162052970 | 33 | 9096 |
One latest value per concept from companyfacts (204 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 32.36M | 2026-11-03 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 31,357.6 | 2026-10-01 | S-3ASR | 2026-10-01 | 0001193125-26-410651 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 45,001.54 | 2026-10-01 | S-3ASR | 2026-10-01 | 0001193125-26-410651 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 517.26M | 2026-10-01 | S-3ASR | 2026-10-01 | 0001193125-26-410651 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 13,643.94 | 2026-10-01 | S-3ASR | 2026-10-01 | 0001193125-26-410651 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-10-01 | S-3ASR | 2026-10-01 | 0001193125-26-410651 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 6.88M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 441,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | AccruedInsuranceCurrent | Accrued Insurance, Current | USD | 101,000 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001193125-25-268174 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 22.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 1.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 723,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -545,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 677.43M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 3.67M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 504,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 3.42M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | Assets | Assets | USD | 453.37M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 447.12M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 1,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 546,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 403.78M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 310.74M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001193125-25-268174 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 215.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 403.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 215.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 215.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -35.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1 | Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments | USD | -804,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 116,939 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 500.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 32.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 32.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 3,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -130.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | ConvertiblePreferredStockSharesIssuedUponConversion | Convertible Preferred Stock, Shares Issued upon Conversion | shares | 0 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 | |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 1,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 1,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | USD | 0 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-11 | 0001193125-26-343490 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPosition | Debt Securities, Available-for-sale, Unrealized Loss Position | USD | 189.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 531,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 | |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 30.20M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 531,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 14.91M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsDomestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic | USD | 70.30M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal | Deferred Tax Assets, Operating Loss Carryforwards, State and Local | USD | 41.70M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 4.87M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 1.14M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals | USD | 1,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 29.67M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 | |
| us-gaap | DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities | Deferred Tax Liabilities, Unrealized Gains on Trading Securities | USD | 35,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 | |
| us-gaap | Depreciation | Depreciation | USD | 303,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 300,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 321,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 |
| us-gaap | DerivativeLiabilitiesCurrent | Derivative Liability, Current | USD | 1.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | DerivativeLiabilitiesNoncurrent | Derivative Liability, Noncurrent | USD | 1.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -4.25 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -4.25 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.249 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0.021 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.003 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | -0.018 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 |
| us-gaap | EmployeeRelatedLiabilitiesCurrentAndNoncurrent | Employee-related Liabilities | USD | 3.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense | Share-based Payment Arrangement, Expense, Tax Benefit | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | -1.60M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | FinancingReceivableAllowanceForCreditLosses | Financing Receivable, Allowance for Credit Loss | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments | Gain (Loss) on Interest Rate Derivative Instruments Not Designated as Hedging Instruments | USD | -804,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | GainLossOnSaleOfDerivatives | Gain (Loss) on Sale of Derivatives | USD | -200,000 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001193125-26-219607 |
| us-gaap | GainLossOnSaleOfInvestments | Gain (Loss) on Sale of Investments | USD | 3,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 28.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | ImpairmentOfIntangibleAssetsFinitelived | Impairment of Intangible Assets, Finite-lived | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -129.72M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 1,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | 22.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | IncreaseDecreaseInAccruedInterestReceivableNet | Increase (Decrease) in Accrued Interest Receivable, Net | USD | -217,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -216,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 29.56M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 9.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | IssuanceOfStockAndWarrantsForServicesOrClaims | Issuance of Stock and Warrants for Services or Claims | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 |
| us-gaap | LandSubjectToGroundLeases | Land Subject to Ground Leases | sqft | 4,600 | 2025-11-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | LeaseCost | Lease, Cost | USD | 580,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 6.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 968,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 1.16M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 775,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 1.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 1.21M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 1.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 254,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 1.48M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | Liabilities | Liabilities | USD | 35.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 453.37M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 30.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 44.68M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-11 | 0001193125-26-343490 | |
| us-gaap | MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss | USD | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-11 | 0001193125-26-343490 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 234.73M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -144.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -125.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -129.72M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -129.72M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 8.79M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 138.52M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 573,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 5.16M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 956,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 4.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 548,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 3.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.096 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 161,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-11 | 0001193125-26-343490 | |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | -713,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax | USD | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-11 | 0001193125-26-343490 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -731,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | OtherEmployeeRelatedLiabilitiesCurrent | Other Employee-related Liabilities, Current | USD | 709,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | PaymentsForRestructuring | Payments for Restructuring | USD | 1.04M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 9.75M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-11 | 0001193125-26-343490 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 465,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | PaymentsToAcquireShortTermInvestments | Payments to Acquire Short-term Investments | USD | 166.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent | Liability, Pension and Other Postretirement and Postemployment Benefits, Current | USD | 798,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-11 | 0001193125-26-343490 | |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 43.36M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | PrepaidInsurance | Prepaid Insurance | USD | 460,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-11 | 0001193125-26-343490 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 250.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock | Proceeds from Issuance of Redeemable Convertible Preferred Stock | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 |
| us-gaap | ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | USD | 2.50M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 |
| us-gaap | ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities | Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities | USD | 10.20M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-11 | 0001193125-26-343490 |
| us-gaap | ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments | Proceeds from Maturities, Prepayments and Calls of Short-term Investments | USD | 20.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | ProceedsFromSaleOfAvailableForSaleSecuritiesDebt | Proceeds from Sale of Debt Securities, Available-for-sale | USD | 2.50M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 |
| us-gaap | ProceedsFromSaleOfHeldToMaturitySecurities | Proceeds from Sale of Held-to-maturity Securities | USD | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-11 | 0001193125-26-343490 |
| us-gaap | ProceedsFromSaleOfShortTermInvestments | Proceeds from Sale of Short-term Investments | USD | 1.41M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 59,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 60,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 2.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 2.15M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | RecapitalizationCosts | Recapitalization Costs | USD | 0 | 2025-07-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001193125-25-268174 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 110.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 788,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 788,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 700,000 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001193125-25-268174 |
| us-gaap | RestructuringReserve | Restructuring Reserve | USD | 445,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -259.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 1.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | SeveranceCosts1 | Severance Costs | USD | 967,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 11.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares | 23 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.867 | 2025-01-01 | 2025-06-30 | 2026 | Q2 | 10-Q | 2026-08-11 | 0001193125-26-343490 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.044 | 2025-01-01 | 2025-06-30 | 2026 | Q2 | 10-Q | 2026-08-11 | 0001193125-26-343490 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | shares | 0 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001193125-25-268174 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 146,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | USD/shares | 15.6 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 100,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | shares | 100,000 | 2024-01-01 | 2024-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001193125-25-268174 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 981,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 35.14 | 2025-01-01 | 2025-06-30 | 2026 | Q2 | 10-Q | 2026-08-11 | 0001193125-26-343490 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 66.44M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 3.42M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 19.26 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number | shares | 729,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price | USD/shares | 15.68 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 3.42M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 19.26 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 15 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 27.91 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | SharePrice | Share Price | USD/shares | 34.94 | 2026-07-28 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | SharesIssuedPricePerShare | Shares Issued, Price Per Share | USD/shares | 34.94 | 2026-07-28 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 188.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 0 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001193125-26-219607 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 417.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 | |
| us-gaap | StockIssuedDuringPeriodSharesIssuedForServices | Stock Issued During Period, Shares, Issued for Services | shares | 1,433 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 464 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 4,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfUnits | Stock Issued During Period, Value, Conversion of Units | USD | 114.26M | 2025-07-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | StockIssuedDuringPeriodValueIssuedForServices | Stock Issued During Period, Value, Issued for Services | USD | 71,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 302.31M | 2025-07-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 9,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 114.26M | 2024-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 | |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 120.48M | 2024-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 79.25M | 2024-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 78.07M | 2024-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 78.07M | 2024-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 6.30M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 7,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | WeightedAverageNumberDilutedSharesOutstandingAdjustment | Weighted Average Number Diluted Shares Outstanding Adjustment | shares | 30.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 30.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 30.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449994 |
| us-gaap | WriteOffOfDeferredDebtIssuanceCost | Write off of Deferred Debt Issuance Cost | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126368 |